Mawer Investment Management Ltd. Buys 10,368 Shares of McKesson Corporation $MCK

Mawer Investment Management Ltd. raised its holdings in shares of McKesson Corporation (NYSE:MCK – Free Report) by 5.7% during the third quarter, Holdings Channel reports. The fund owned 190,817 shares of the company’s stock after buying an additional 10,368 shares during the period. McKesson comprises about 1.2% of Mawer Investment Management Ltd.’s investment portfolio, making the stock its 25th biggest position. Mawer Investment Management Ltd.’s holdings in McKesson were worth $162,921,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of MCK. Cornerstone Advisory LLC raised its stake in McKesson by 7.0% in the third quarter. Cornerstone Advisory LLC now owns 367 shares of the company’s stock worth $313,000 after buying an additional 24 shares in the last quarter. BankPlus Trust Department raised its position in shares of McKesson by 72.1% in the 3rd quarter. BankPlus Trust Department now owns 1,805 shares of the company’s stock worth $1,541,000 after purchasing an additional 756 shares during the last quarter. Aberdeen Group plc increased its stake in McKesson by 143.4% during the 3rd quarter. Aberdeen Group plc now owns 296,426 shares of the company’s stock valued at $253,091,000 after purchasing an additional 174,642 shares in the last quarter. Moors & Cabot Inc. increased its stake in McKesson by 3.9% during the 3rd quarter. Moors & Cabot Inc. now owns 3,081 shares of the company’s stock valued at $2,631,000 after purchasing an additional 115 shares in the last quarter. Finally, Money Concepts Capital Corp raised its holdings in McKesson by 20.3% in the third quarter. Money Concepts Capital Corp now owns 2,179 shares of the company’s stock worth $1,860,000 after buying an additional 368 shares during the last quarter. 85.07% of the stock is currently owned by hedge funds and other institutional investors.

McKesson Price Performance

McKesson stock traded up $26.26 during midday trading on Friday, reaching $1,103.31. 527,403 shares of the company traded hands, compared to its average volume of 716,694. McKesson Corporation has a 12 month low of $723.68 and a 12 month high of $1,121.50. The business has a 50 day moving average of $955.45 and a two-hundred day moving average of $874.53. The firm has a market capitalization of $127.39 billion, a price-to-earnings ratio of 28.37, a price-to-earnings-growth ratio of 1.82 and a beta of 0.27.

McKesson (NYSE:MCK – Get Free Report) last announced its earnings results on Wednesday, November 4th. The company reported $11.68 earnings per share for the quarter, beating analysts’ consensus estimates of $10.72 by $0.96. The business had revenue of $110.96 billion during the quarter, compared to analyst estimates of $109.90 billion. McKesson had a net margin of 1.12% and a negative return on equity of 202.94%. The company’s quarterly revenue was up 7.5% compared to the same quarter last year. During the same period in the previous year, the business earned $9.86 EPS. As a group, equities analysts forecast that McKesson Corporation will post 46.16 EPS for the current year.

McKesson Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, January 4th. Investors of record on Tuesday, December 1st will be issued a $0.94 dividend. The ex-dividend date of this dividend is Tuesday, December 1st. This represents a $3.76 annualized dividend and a dividend yield of 0.3%. McKesson’s payout ratio is presently 9.67%.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the stock. Evercore reiterated an “outperform” rating and issued a $950.00 target price (down from $1,000.00) on shares of McKesson in a research note on Thursday, August 6th. Royal Bank Of Canada upped their price objective on McKesson from $845.00 to $965.00 and gave the company a “sector perform” rating in a research report on Thursday, November 5th. Morgan Stanley set a $977.00 target price on McKesson in a research note on Tuesday, October 6th. Wells Fargo & Company lifted their target price on McKesson from $812.00 to $933.00 and gave the stock an “equal weight” rating in a report on Tuesday, August 11th. Finally, UBS Group boosted their price target on McKesson from $1,200.00 to $1,250.00 and gave the stock a “buy” rating in a research note on Thursday, November 5th. Fifteen investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, McKesson presently has a consensus rating of “Moderate Buy” and an average target price of $1,040.29.

Get Our Latest Research Report on McKesson

Insider Buying and Selling at McKesson

In other McKesson news, EVP Francisco Fraga sold 650 shares of the firm’s stock in a transaction dated Thursday, November 5th. The stock was sold at an average price of $1,102.96, for a total value of $716,924.00. Following the transaction, the executive vice president directly owned 4,414 shares of the company’s stock, valued at approximately $4,868,465.44. This trade represents a 12.84% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Napoleon B. Rutledge, Jr. sold 111 shares of the business’s stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $891.45, for a total value of $98,950.95. Following the sale, the chief accounting officer owned 521 shares of the company’s stock, valued at approximately $464,445.45. This represents a 17.56% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 2,161 shares of company stock valued at $2,242,515 in the last ninety days. 0.06% of the stock is currently owned by corporate insiders.

McKesson Profile

(Free Report)

McKesson Corporation is a healthcare services and information technology company that distributes pharmaceuticals and other medical products. Its customers include pharmacies, hospitals, health systems, clinics and other healthcare providers. The company also provides medical-surgical supplies and technology and services that support pharmacy operations, prescription management and care delivery. Its offerings include specialized support for oncology and other areas of care. Founded in 1833, McKesson serves customers primarily in the United States and Canada.

Further Reading

Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Corporation (NYSE:MCK – Free Report).

Institutional Ownership by Quarter for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.